Lumito AB (NGM:LUMITO) Total Liabilities: kr11.54 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:LUMITO Lumito AB NGM:LUMITO
18 GF Score
Price kr2.37
! 2 Warning Signs
View Full Analysis

What is Lumito AB Total Liabilities?

Lumito AB NGM:LUMITO +10.00% 18 Total Liabilities is kr11.54 Mil as of Mar. 2026. GuruFocus rates NGM:LUMITO with a GF Score™ of 18/100. The stock has 2 warning signs investors should review.

Lumito AB's Total Liabilities for the quarter that ended in Mar. 2026 was kr11.54 Mil.

Lumito AB's quarterly Total Liabilities declined from Sep. 2025 (kr21.39 Mil) to Dec. 2025 (kr12.12 Mil) and declined from Dec. 2025 (kr12.12 Mil) to Mar. 2026 (kr11.54 Mil).

Lumito AB's annual Total Liabilities increased from Dec. 2023 (kr18.28 Mil) to Dec. 2024 (kr19.31 Mil) but then declined from Dec. 2024 (kr19.31 Mil) to Dec. 2025 (kr12.12 Mil).


Lumito AB Total Liabilities Historical Data

* Premium members only.

The historical data trend for Lumito AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumito AB Total Liabilities Chart

Lumito AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 8.41 6.83 18.28 19.31 12.12

Lumito AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.24 18.05 21.39 12.12 11.54
NGM:LUMITO
18GF Score
Lumito AB NGM:LUMITO
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lumito AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Lumito AB's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=87.937-75.819
=12.12

Lumito AB's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=76.82-65.283
=11.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of kr11.54 Mil mean?
Lumito AB (NGM:LUMITO) has a Total Liabilities of kr11.54 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Lumito AB and its competitors.
Is Lumito AB's Total Liabilities too high?
Lumito AB's current Total Liabilities is kr11.54 Mil. Overall, Lumito AB has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Lumito AB's Total Liabilities compare to TMO and DHR?
Lumito AB's Total Liabilities of kr11.54 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Lumito AB and its competitors. Lumito AB's current Total Liabilities is kr11.54 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumito AB stock overvalued right now?
Lumito AB (NGM:LUMITO) has a current Total Liabilities of kr11.54 Mil. The current Total Liabilities is kr11.54 Mil. Lumito AB's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Lumito AB (NGM:LUMITO), the current Total Liabilities is kr11.54 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lumito AB Business Description

Address Scheelevagen 19, Lund, SWE, 223 63
Lumito AB is a Swedish company that specializes in the medical research and development of imaging technology for use in digital pathology. It has developed the next-generation tissue analysis system, based on upconverting nanoparticles (UCNPs). Lumito SCIZYS is a cutting-edge, high-sensitivity system combining labeling and imaging technologies to locate and measure biomarkers in tissue samples. The company holds a broad patent portfolio of three patent families. Lumito's solution enables quantitative and objective assessment of tissue samples, addressing a multitude of challenges in drug development and academic research.
18GF Score

Get the complete analysis for NGM:LUMITO

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.37
Price